Asia-Pacific Investigators and Asian Enrollment in Cardiometabolic Trials: Insights From Publications Between 2011 and 2020.

Conclusions Despite a favorable trend over the past decade, Asian participants and authors from APAC remain significantly underrepresented in seminal cardiometabolic trials; barriers to trial conduct and leadership in this region must be addressed.

also in 559 other papers

Whereas there is an encouraging trend toward increased trial leadership and collaboration from APAC, the absolute numbers remain low, and temporal improvements are marginal and limited to higher-income regions such as East Asia and Oceania.

also in 133 other papers